COST ACTION 920

Inventory of QMRA Studies in Europe


Data sheet

Pathogen

 Streptogramin-resistant Enterococcus faecium (SREf)

Country or region

 US

Transmission route

 From

 Farm

To

 Consumption

Specific product(s)

 Chicken

End-point(s)

Probability of human exposure to SREf from the consumption of chicken


Reports or publications

Bibliographic reference

·         Snary, E.,Smith, D.,Kelly, L.,Morris, G. & Wooldridge, M. (2000).  The development of streptogramin resistant Enterococci faecium within the human population due to the use of virginiamycin in broilers - a risk assessment approach.  In Society for Risk Analysis.  SRA 2000:  Applications of Risk Analysis in Industry and Government, (Arlington, Virginia, US).

·         Snary, E; Kelly, LA & Wooldridge, M (2002): An exposure assessment for streptogramin-resistant
Enterococcus faecium.  Report to Pfizer Animal Health

·         Kelly, L; Smith, DL; Snary, EL; Johnson, JA; Harris, AD; Wooldridge, M & Morris, Jnr, JG (in press).  Animal growth promoters: to ban or not to ban? A risk assessment approach.  International Journal Of Antimicrobial Agents. 

Abstract

A farm-to-fork exposure assessment was developed to investigate the consequence of a ban in the use of virginiamycin as a growth promoter for broilers in the US.  The model estimates that prior to any such ban, a random human in the US is exposed to SREf through the consumption of chicken at a mean rate of 0.796 (0.538, 1.082) chicken meals per month.  Five years after a ban, it is estimated that the mean rate will decrease by approximately 70%, to a mean rate of 0.238 (0.0873, 0.464) chicken meals per month. 

Status

 Complete

Availability

 From author


Project group

Institute

Veterinary Laboratories Agency, UK

Contact person

Dr. Emma Snary (e.l.snary@vla.defra.gsi.gov.uk)

Partners

·         Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, MD 21201, USA

·         VA Microbiology and Molecular Diagnostics Laboratory, VA Medical Center, Baltimore, MD 21201, USA